Characterisation of the DNA sequence specificity, cellular toxicity and cross-linking properties of novel bispyridine-based dinuclear platinum complexes

被引：0
作者：
Ben W. Johnson
Vincent Murray
Mark D. Temple
机构：
[1] Western Sydney University,School of Science and Health
[2] University of New South Wales,School of Biotechnology and Biomolecular Sciences
来源：
BMC Cancer | / 16卷
关键词：
Anticancer drug; Cisplatin; DNA adducts; Interstrand cross-linking; Sequence specificity; Linear Amplification Reaction; Telomeric repeat;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 275 条
[1]  
Jemal A(2011)Global cancer statistics CA Cancer J Clin 61 69-90
[2]  
Bray F(2015)Global cancer statistics, 2012 CA Cancer J Clin 65 87-108
[3]  
Center MM(2005)Recognition and processing of cisplatin- and oxaliplatin-DNA adducts Crit Rev Oncol Hematol 53 3-11
[4]  
Ferlay J(2005)Double-cycle, high-dose ifosfamide, carboplatin, and etoposide followed by peripheral blood stem-cell transplantation for small cell lung cancer Chest 128 2268-73
[5]  
Ward E(2005)Cellular processing of platinum anticancer drugs Nat Rev Drug Discov 4 307-20
[6]  
Forman D(1987)The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes Pharmac Ther 34 155-66
[7]  
Torre LA(2005)Cisplatin is a DNA-damaging antitumour compound triggering multifactorial biochemical responses in cancer cells: importance of apoptotic pathways Curr Med Chem Anticancer Agents 5 251-65
[8]  
Bray F(1985)Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation Biochemistry 24 707-13
[9]  
Siegel RL(1999)Structure, recognition, and processing of cisplatin-DNA adducts Chem Rev 99 2467-98
[10]  
Ferlay J(1988)A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes Proc Natl Acad Sci 85 6622-6
12345678910